4-methyl-8-(morpholin-4-ylmethyl)-1-(5-propoxypyridin-3-yl)[1,2,4]triazolo[4,3-a]quinoxaline hydrochloride | 1417410-20-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 4-methyl-8-(morpholin-4-ylmethyl)-1-(5-propoxypyridin-3-yl)[1,2,4]triazolo[4,3-a]quinoxaline hydrochloride
• CAS: 1417410-20-8
• 化学式: C₂₃H₂₆N₆O₂*ClH
• 分子量: 454.959
• InChiKey: YTRZNHHCSAICHM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.69
• 重原子数：
  32.0
• 可旋转键数：
  6.0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.39
• 拓扑面积：
  77.67
• 氢给体数：
  0.0
• 氢受体数：
  8.0

反应信息

• 作为产物：
  描述：

  Methyl 5-propoxypyridine-3-carboxylate 在 hydrazine hydrate 、 2-dicyclohexylphosphino-2,4,6-triisopropylbiphenyl 、 palladium diacetate 、 caesium carbonate 作用下， 以 四氢呋喃 、 乙醇 、 水 、 正丁醇 为溶剂， 反应 4.0h， 生成 4-methyl-8-(morpholin-4-ylmethyl)-1-(5-propoxypyridin-3-yl)[1,2,4]triazolo[4,3-a]quinoxaline hydrochloride
  参考文献：
  名称：

  Structure-Based Design of a Potent, Selective, and Brain Penetrating PDE2 Inhibitor with Demonstrated Target Engagement

  摘要：

  Structure-guided design led to the identification of the novel, potent, and selective phosphodiesterase 2 (PDE2) inhibitor 12. Compound 12 demonstrated a >210-fold selectivity versus PDE10 and PDE11 and was inactive against all other PDE family members up to 10 mu M. In vivo evaluation of 12 provided evidence that it is able to engage the target and to increase cGMP levels in relevant brain regions. Hence, 12 is a valuable tool compound for the better understanding of the role of PDE2 in cognitive impairment and other central nervous system related disorders.

  DOI：

  10.1021/ml500262u